These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 8112390)

  • 41. Uncompetitive inhibition of [3H]1,3-di-o-tolyl-guanidine-defined sigma binding sites by desipramine, propranolol and alprenolol in rat brain.
    Shirayama Y; Takahashi K; Nishikawa T
    Eur J Pharmacol; 1997 Jul; 331(2-3):319-23. PubMed ID: 9274995
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differentiation of sigma ligand-activated receptor subtypes that modulate NMDA-evoked [3H]-noradrenaline release in rat hippocampal slices.
    Monnet FP; de Costa BR; Bowen WD
    Br J Pharmacol; 1996 Sep; 119(1):65-72. PubMed ID: 8872358
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Sigma-2 Receptor and Progesterone Receptor Membrane Component 1 are Different Binding Sites Derived From Independent Genes.
    Chu UB; Mavlyutov TA; Chu ML; Yang H; Schulman A; Mesangeau C; McCurdy CR; Guo LW; Ruoho AE
    EBioMedicine; 2015 Nov; 2(11):1806-13. PubMed ID: 26870805
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification and characterization of two sigma-like binding sites in the mouse neuroblastoma x rat glioma hybrid cell line NG108-15.
    Georg A; Friedl A
    J Pharmacol Exp Ther; 1991 Nov; 259(2):479-83. PubMed ID: 1658298
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and evaluation of optically pure [3H]-(+)-pentazocine, a highly potent and selective radioligand for sigma receptors.
    de Costa BR; Bowen WD; Hellewell SB; Walker JM; Thurkauf A; Jacobson AE; Rice KC
    FEBS Lett; 1989 Jul; 251(1-2):53-8. PubMed ID: 2568952
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sigma receptor binding affinity and inhibition of apomorphine-induced climbing.
    Fritz PM; DeHaven-Hudkins DL; Fleissner LC; Ford-Rice FY; Luttinger D
    Eur J Pharmacol; 1993 Apr; 235(2-3):229-35. PubMed ID: 8508904
    [TBL] [Abstract][Full Text] [Related]  

  • 47. p-chlorophenylalanine-reversible reduction of sigma binding sites by chronic imipramine treatment in rat brain.
    Shirayama Y; Nishikawa T; Umino A; Takahashi K
    Eur J Pharmacol; 1993 Jun; 237(1):117-26. PubMed ID: 8359206
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sigma receptor-mediated effects of a new antiulcer agent, KB-5492, on experimental gastric mucosal lesions and gastric alkaline secretion in rats.
    Hara H; Tanaka K; Harada Y; Sukamoto T
    J Pharmacol Exp Ther; 1994 May; 269(2):799-805. PubMed ID: 8182548
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential solubilization of rat liver sigma 1 and sigma 2 receptors: retention of sigma 2 sites in particulate fractions.
    Torrence-Campbell C; Bowen WD
    Eur J Pharmacol; 1996 May; 304(1-3):201-10. PubMed ID: 8813603
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Initial identification and characterization of sigma receptors on human peripheral blood leukocytes.
    Wolfe SA; Kulsakdinun C; Battaglia G; Jaffe JH; De Souza EB
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1114-9. PubMed ID: 2849660
    [TBL] [Abstract][Full Text] [Related]  

  • 51. RLH-033, a novel, potent and selective ligand for the sigma 1 recognition site.
    Hudkins RL; Mailman RB; DeHaven-Hudkins DL
    Eur J Pharmacol; 1994 Dec; 271(1):235-6. PubMed ID: 7698207
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vivo functional interaction between phencyclidine binding sites and sigma receptors to produce head-weaving behavior in rats.
    Kitaichi K; Noda Y; Hasegawa T; Furukawa H; Nabeshima T
    Eur J Pharmacol; 1996 Dec; 318(2-3):205-11. PubMed ID: 9016907
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential labeling of dopamine and sigma sites by [3H]nemonapride and [3H]raclopride in postmortem human brains.
    Tang SW; Helmeste DM; Fang H; Li M; Vu R; Bunney W; Potkin S; Jones EG
    Brain Res; 1997 Aug; 765(1):7-12. PubMed ID: 9310388
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Up-regulation of [3H]DTG but not [3H](+)-pentazocine labeled sigma sites in mouse spinal cord by chronic morphine treatment.
    Kovács KJ; Larson AA
    Eur J Pharmacol; 1998 May; 350(1):47-52. PubMed ID: 9683013
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sigma-2 receptors are specifically localized to lipid rafts in rat liver membranes.
    Gebreselassie D; Bowen WD
    Eur J Pharmacol; 2004 Jun; 493(1-3):19-28. PubMed ID: 15189760
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacological and autoradiographic discrimination of sigma and phencyclidine receptor binding sites in brain with (+)-[3H]SKF 10,047, (+)-[3H]-3-[3-hydroxyphenyl]-N-(1-propyl)piperidine and [3H]-1-[1-(2-thienyl)cyclohexyl]piperidine.
    Largent BL; Gundlach AL; Snyder SH
    J Pharmacol Exp Ther; 1986 Aug; 238(2):739-48. PubMed ID: 3016248
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sigma receptors in post-mortem human brains.
    Weissman AD; Su TP; Hedreen JC; London ED
    J Pharmacol Exp Ther; 1988 Oct; 247(1):29-33. PubMed ID: 2845055
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The sigma receptor ligand 1,3-di-(2-tolyl)guanidine in animal models of schizophrenia.
    Rückert NG; Schmidt WJ
    Eur J Pharmacol; 1993 Mar; 233(2-3):261-7. PubMed ID: 8467871
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacological identification of SM-21, the novel sigma(2) antagonist.
    Ghelardini C; Galeotti N; Bartolini A
    Pharmacol Biochem Behav; 2000 Nov; 67(3):659-62. PubMed ID: 11164098
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An absence of changes in sigma receptor subtypes in the brains of genetically dystonic (dt) rats.
    Weissman AD; McCann DJ; Lorden JF; Su TP
    Eur J Pharmacol; 1993 Dec; 250(2):329-32. PubMed ID: 8112390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.